Related Experiment Video
Updated: May 7, 2025

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
Unraveling the protein kinase C/NDRG1 signaling network in breast cancer
C Saponaro1, M Damato2, E Stanca2
1Pathology Department, IRCCS Istituto Tumori "Giovanni Paolo II", 70124, Bari, Italy.
Abstract:
N-myc downstream-regulated gene 1 (NDRG1) is a member of the NDRG family of intracellular proteins and plays a central role in a wide range of biological processes including stress response, differentiation, and metabolism. The overexpression of NDRG1 is an indicator of poor prognosis in various types of cancer. Here, we found that NDRG1 is an independent prognostic marker of poor outcome in breast cancer (BC). Analysis of the TCGA dataset showed a significant positive correlation between NDRG1 and PRKCA expression, suggesting a mechanistic role of protein kinase C (PKC) in the regulation of NDRG1. We then assessed the hypothesis that PKC might modulate the activity of NDRG1, and observed that different acute stress conditions converging on PKC activation lead to enhanced NDRG1 expression. This mechanism was found to be specific for NDRG1 as the expression of other NDRG members was not affected. Moreover, CRISPR-based inhibition of NDRG1 expression was obtained in a BC cell line, and showed that this protein is a key driver of BC cell invasion through the Rho-associated coiled-coil containing protein kinase 1 (ROCK1)/phosphorylated cofilin pathway that regulates stress fiber assembly, and the modulation of extracellular matrix reorganization related genes. Together, our findings highlight the potential of NDRG1 as a new BC biomarker and uncover a novel mechanism of regulation of NDRG1 expression that might lead to innovative therapeutic strategies.
Insights
N-myc downstream-regulated gene 1 (NDRG1) is a poor prognostic marker in breast cancer (BC). Protein kinase C (PKC) activation enhances NDRG1 expression, driving BC cell invasion via the ROCK1/cofilin pathway.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- N-myc downstream-regulated gene 1 (NDRG1) is implicated in cellular processes and linked to poor prognosis in various cancers.
- Overexpression of NDRG1 correlates with adverse outcomes in breast cancer (BC).
Purpose of the Study:
- To investigate NDRG1 as a prognostic marker in breast cancer.
- To elucidate the regulatory mechanisms of NDRG1 expression and its role in BC progression.
Main Methods:
- Analysis of TCGA dataset for NDRG1 and PRKCA expression correlation.
- Induction of NDRG1 expression under acute stress conditions activating protein kinase C (PKC).
- CRISPR-based inhibition of NDRG1 in a BC cell line to assess its role in invasion.
Main Results:
- NDRG1 is an independent prognostic marker of poor outcome in breast cancer.
- A positive correlation between NDRG1 and PRKCA suggests PKC regulates NDRG1 expression.
- PKC activation enhances NDRG1 expression specifically, not other NDRG family members.
- NDRG1 drives BC cell invasion through the ROCK1/cofilin pathway, impacting stress fibers and extracellular matrix.
Conclusions:
- NDRG1 serves as a potential biomarker for poor prognosis in breast cancer.
- A novel PKC-mediated pathway regulates NDRG1 expression.
- Targeting NDRG1 may offer new therapeutic strategies for breast cancer.
More Related Videos
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
MAPK Signaling Cascades
Amplifying Signals via Enzymatic Cascade
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...

